![]() |
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
Sponsored by: |
Baystate Medical Center |
---|---|
Information provided by: | Baystate Medical Center |
ClinicalTrials.gov Identifier: | NCT00666003 |
Fluid and volume management are a challenging part of critical care and the difficulties increase in the face of renal failure. Utilizing the Crit-Line to monitor blood volume changes in conjunction with arterial pressure cardiac output monitoring may lead to better understanding of the impact fluid removal during dialysis has on hemodynamics.
Condition |
---|
Renal Failure Hemodynamics |
Study Type: | Observational |
Study Design: | Cohort, Prospective |
Official Title: | Hemodynamic Assessment Comparison Between Arterial Pressure Cardiac Output Monitor and Crit Line Utilized During Renal Replacement Therapy |
Estimated Enrollment: | 30 |
Study Start Date: | April 2008 |
Estimated Study Completion Date: | July 2009 |
Estimated Primary Completion Date: | June 2009 (Final data collection date for primary outcome measure) |
Patients in an ICU often require large amounts of IV fluid to maintain adequate cardiac function. In patients with renal failure, the ability to gauge adequacy of circulating blood volume based on urine output is obviously lacking. The FDA approved devices called Flotrac/Vigileo and Crit-Line are used in this setting to determine adequacy of fluid resuscitation. This study proposes to use the data collected in a retrospective manner to determine if correlation of the various measured parameters can serve as a predictor of hemodynamic status.
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Non-Probability Sample |
Renal Failure Patients in the ICU
Inclusion Criteria:
Exclusion Criteria:
Contact: Patrick Mailloux, D.O. | 413-794-5439 | patrick.mailloux@bhs.org |
United States, Massachusetts | |
Baystate Medical Center | Recruiting |
Springfield, Massachusetts, United States, 01199 | |
Contact: Patrick Mailloux, D.O. 413-794-5439 patrick.mailloux@bhs.org | |
Principal Investigator: Patrick Mailloux, D.O. |
Principal Investigator: | Patrick Mailloux, D.O. | Baystate Medical Center |
Responsible Party: | Baystate Medical Cetner ( Patrick T. Mailloux, DO ) |
Study ID Numbers: | IRB07-120 |
Study First Received: | April 23, 2008 |
Last Updated: | December 24, 2008 |
ClinicalTrials.gov Identifier: | NCT00666003 History of Changes |
Health Authority: | United States: Institutional Review Board |
Hemodynamics |
Renal Insufficiency Urologic Diseases Kidney Diseases Kidney Failure |
Renal Insufficiency Urologic Diseases Kidney Diseases Kidney Failure |